Business Wire

Rheos Medicines Appoints Sanjay Keswani as Chief Executive Officer to Lead Company’s Pioneering Drug Development in Immunometabolism

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rheos Medicines, a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease, today announced the ...
Yahoo Finance

Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Nasdaq

Sanjay Keswani To Succeed Eiry Roberts As CMO

(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) Friday said it has appointed Sanjay Keswani as its chief medical officer (CMO) effective June 2, 2025. Keswani succeeds Eiry W. Roberts, who will remain ...
Mena FN

Immunobrain Checkpoint Appoints Dr. Sanjay Keswani As Chief Executive Officer

ImmunoBrain Checkpoint Inc. (ImmunoBrain), a clinical stage biopharmaceutical company developing innovative disease-modifying immune therapies to combat neurodegenerative diseases, today announced the ...
FierceBiotech

Third Rock’s Rheos poaches Sanjay Keswani from Roche

Third Rock Ventures’ Rheos Medicines has named former Roche SVP Sanjay Keswani, M.D., as CEO. The appointment puts Keswani in charge of overseeing Rheos’ pipeline of immunometabolism assets. Rheos ...
Yahoo Finance

Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer

SAN DIEGO, April 4, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Sanjay Keswani, M.D., to the company's executive management team as Chief ...